The nicotinamide phosphoribosyltransferase antagonist FK866 inhibits growth of prostate tumour spheroids and increases doxorubicin retention without changes in drug transporter and cancer stem cell protein expression

Sauer, HeinrichHeinrichSauerKampmann, HenningHenningKampmannKhosravi, FarhadFarhadKhosraviSharifpanah, FatemehFatemehSharifpanahWartenberg, MariaMariaWartenberg2022-09-052022-09-052021https://jlupub.ub.uni-giessen.de/handle/jlupub/7373http://dx.doi.org/10.22029/jlupub-6824enNamensnennung - Nicht kommerziell 4.0 Internationalddc:610The nicotinamide phosphoribosyltransferase antagonist FK866 inhibits growth of prostate tumour spheroids and increases doxorubicin retention without changes in drug transporter and cancer stem cell protein expression